On pg.3 of the MD&A report from the latest Financials release (SEDAR) of Sept 27, 2019, this is a quote directly from the document:
"Acreage Pharms is also on track to enter into the European market with a five year 10,000kg supply agreement with
a Germany company, as its Phase III facility is being built to be EU-GMP compliant".
Of course there will be no other update until the licenses, certifications etc. are made. This is normal public business protocol.